Brice Laffleur

Title: Brice Laffleur: Innovator in Transgenic Technology

Introduction

Brice Laffleur is a notable inventor based in Limoges, France. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human mammals for medical applications. His work focuses on producing chimeric human immunoglobulin E antibodies, which have important implications for immunology and therapeutic interventions.

Latest Patents

Brice Laffleur holds a patent for a "Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies." This invention involves a transgenic non-human mammal that comprises human immunoglobulin mu and epsilon heavy-chain constant transgenes Cμ and Cε. These transgenes are inserted in place of the endogenous mu heavy-chain switch sequence Sμ, allowing for the production of chimeric human immunoglobulin E antibodies that are specific for an antigen of interest. He has 1 patent to his name.

Career Highlights

Throughout his career, Brice has worked with various organizations that have contributed to his expertise in the field. Notably, he has been associated with B Cell Design and Université De Limoges. His work in these institutions has allowed him to advance his research and develop innovative solutions in biotechnology.

Collaborations

Brice has collaborated with several professionals in his field, including Michel Cogne and Armelle Cuvillier. These collaborations have enriched his research and contributed to the advancement of transgenic technology.

Conclusion

Brice Laffleur is a pioneering inventor whose work in transgenic technology has the potential to impact the field of immunology significantly. His innovative approach to producing chimeric human antibodies showcases the importance of research and collaboration in advancing medical science.